NDABUCCAL, SUBLINGUALTABLET
Approved
Sep 2006
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Clinical Trials
4
Data completeness
5/8 — Partial
FENTORA (fentanyl citrate) by Teva is analgesia. First approved in 2006.
Drug data last refreshed 15h ago · AI intelligence enriched 18h ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
FENTORA (fentanyl citrate) is a potent opioid analgesic delivered via buccal or sublingual tablet formulation for rapid onset pain relief. It works by binding to opioid receptors in the central nervous system to produce analgesia. The product is indicated for opioid-tolerant patients requiring breakthrough pain management.
$0.001BPart D
LOE ApproachingDeclining
1.7 years to LOEMinimal current investment with LOE imminent; brand team will focus on managed decline and generic transition support rather than growth initiatives.
Mechanism of Action
analgesia.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (4)
Effentora® in Clinical Practice - a Non-interventional Study to Evaluate Satisfaction and Tolerability
Started Jul 2011
600 enrolled
CancerPain
Study to Evaluate the Efficacy and Safety of OraVescent Fentanyl Citrate Treatment for the Management of Breakthrough Pain in Opioid-Tolerant Patients With Noncancer-Related Chronic Pain
Started Aug 2006
120 enrolled
Pain
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for Management of Breakthrough Pain
Started Sep 2005
Chronic Low Back Pain
Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain
Started Sep 2005
120 enrolled
Chronic Neuropathic Pain
Why This Matters for Your Career
Worked on FENTORA at Teva? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.